Literature DB >> 21855651

Emerging roles for retinoids in regeneration and differentiation in normal and disease states.

Lorraine J Gudas1.   

Abstract

The vitamin A (retinol) metabolite, all-trans retinoic acid (RA), is a signaling molecule that plays key roles in the development of the body plan and induces the differentiation of many types of cells. In this review the physiological and pathophysiological roles of retinoids (retinol and related metabolites) in mature animals are discussed. Both in the developing embryo and in the adult, RA signaling via combinatorial Hox gene expression is important for cell positional memory. The genes that require RA for the maturation/differentiation of T cells are only beginning to be cataloged, but it is clear that retinoids play a major role in expression of key genes in the immune system. An exciting, recent publication in regeneration research shows that ALDH1a2 (RALDH2), which is the rate-limiting enzyme in the production of RA from retinaldehyde, is highly induced shortly after amputation in the regenerating heart, adult fin, and larval fin in zebrafish. Thus, local generation of RA presumably plays a key role in fin formation during both embryogenesis and in fin regeneration. HIV transgenic mice and human patients with HIV-associated kidney disease exhibit a profound reduction in the level of RARβ protein in the glomeruli, and HIV transgenic mice show reduced retinol dehydrogenase levels, concomitant with a greater than 3-fold reduction in endogenous RA levels in the glomeruli. Levels of endogenous retinoids (those synthesized from retinol within cells) are altered in many different diseases in the lung, kidney, and central nervous system, contributing to pathophysiology. This article is part of a Special Issue entitled Retinoid and Lipid Metabolism.
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855651      PMCID: PMC3237723          DOI: 10.1016/j.bbalip.2011.08.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  127 in total

1.  Retinoid treatment of Emphysema in Patients on the Alpha-1 International Registry. The REPAIR study: study design, methodology and quality control of study assessments.

Authors:  Jan Stolk; Brendan G Cooper; Berend Stoel; Alexis Rames; Olga Rutman; Sherif Soliman; Robert Stockley
Journal:  Ther Adv Respir Dis       Date:  2010-10-06       Impact factor: 4.031

2.  Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals.

Authors:  Rui Wang; Guoqing Wang; Megan J Ricard; Barbara Ferris; Yael Strulovici-Barel; Jacqueline Salit; Neil R Hackett; Lorraine J Gudas; Ronald G Crystal
Journal:  Chest       Date:  2010-08-12       Impact factor: 9.410

3.  Vitamin A-dependent transcriptional activation of the nuclear factor of activated T cells c1 (NFATc1) is critical for the development and survival of B1 cells.

Authors:  Mikako Maruya; Keiichiro Suzuki; Hanae Fujimoto; Michio Miyajima; Osami Kanagawa; Teruhiko Wakayama; Sidonia Fagarasan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 4.  Retinoids regulate stem cell differentiation.

Authors:  Lorraine J Gudas; John A Wagner
Journal:  J Cell Physiol       Date:  2011-02       Impact factor: 6.384

5.  Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.

Authors:  Gilles Boschetti; Stéphane Nancey; Fatima Sardi; Xavier Roblin; Bernard Flourié; Dominique Kaiserlian
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

6.  Retinoic acid-induced CCR9 expression requires transient TCR stimulation and cooperativity between NFATc2 and the retinoic acid receptor/retinoid X receptor complex.

Authors:  Yoshiharu Ohoka; Aya Yokota; Hajime Takeuchi; Naoko Maeda; Makoto Iwata
Journal:  J Immunol       Date:  2010-12-08       Impact factor: 5.422

7.  Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid.

Authors:  Sabien van Neerven; Andrei Nemes; Philipp Imholz; Tommy Regen; Bernd Denecke; Sonja Johann; Cordian Beyer; Uwe-Karsten Hanisch; Jörg Mey
Journal:  J Neuroimmunol       Date:  2010-09-09       Impact factor: 3.478

8.  The three-dimensional architecture of Hox cluster silencing.

Authors:  Maria A Ferraiuolo; Mathieu Rousseau; Carol Miyamoto; Solomon Shenker; Xue Qing David Wang; Michelle Nadler; Mathieu Blanchette; Josée Dostie
Journal:  Nucleic Acids Res       Date:  2010-07-25       Impact factor: 16.971

9.  Retinoid X receptor gamma signaling accelerates CNS remyelination.

Authors:  Jeffrey K Huang; Andrew A Jarjour; Brahim Nait Oumesmar; Christophe Kerninon; Anna Williams; Wojciech Krezel; Hiroyuki Kagechika; Julien Bauer; Chao Zhao; Anne Baron-Van Evercooren; Pierre Chambon; Charles Ffrench-Constant; Robin J M Franklin
Journal:  Nat Neurosci       Date:  2010-12-05       Impact factor: 24.884

10.  Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid.

Authors:  Ling Lu; Xiaohui Zhou; Julie Wang; Song Guo Zheng; David A Horwitz
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

View more
  80 in total

1.  Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase.

Authors:  Philippe Diaz; Weize Huang; Charles M Keyari; Brian Buttrick; Lauren Price; Nicolas Guilloteau; Sasmita Tripathy; Vanessa G Sperandio; Frank R Fronczek; Fanny Astruc-Diaz; Nina Isoherranen
Journal:  J Med Chem       Date:  2016-03-15       Impact factor: 7.446

2.  A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.

Authors:  Steven E Trasino; Xiao-Han Tang; Jose Jessurun; Lorraine J Gudas
Journal:  J Mol Med (Berl)       Date:  2016-06-06       Impact factor: 4.599

Review 3.  Barrett oesophagus: lessons on its origins from the lesion itself.

Authors:  Stuart A C McDonald; Danielle Lavery; Nicholas A Wright; Marnix Jansen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-11-04       Impact factor: 46.802

4.  All-trans retinoic acid mitigates methotrexate-induced liver injury in rats; relevance of retinoic acid signaling pathway.

Authors:  Mohamed G Ewees; Tamer M Abdelghany; Abdel-Aziz H Abdel-Aziz; Mohamed S Abdel-Bakky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-14       Impact factor: 3.000

5.  The fat-soluble vitamins 100 years later: where are we now?

Authors:  William S Blaner
Journal:  J Lipid Res       Date:  2013-05-07       Impact factor: 5.922

6.  Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.

Authors:  Ariel R Topletz; Sasmita Tripathy; Robert S Foti; Jakob A Shimshoni; Wendel L Nelson; Nina Isoherranen
Journal:  Mol Pharmacol       Date:  2014-12-09       Impact factor: 4.436

7.  Retinoic acid biosynthesis catalyzed by retinal dehydrogenases relies on a rate-limiting conformational transition associated with substrate recognition.

Authors:  Raphaël Bchini; Vasilis Vasiliou; Guy Branlant; François Talfournier; Sophie Rahuel-Clermont
Journal:  Chem Biol Interact       Date:  2012-12-07       Impact factor: 5.192

8.  A Retinoic Acid β2-Receptor Agonist Exerts Cardioprotective Effects.

Authors:  Alice Marino; Takuya Sakamoto; Xiao-Han Tang; Lorraine J Gudas; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2018-06-15       Impact factor: 4.030

9.  Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.

Authors:  Wanjing Ding; Hiroyuki Shimada; Lin Li; Rahul Mittal; Xiaokun Zhang; Koichi Shudo; Qiaojun He; Nemani V Prasadarao; Lingtao Wu
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

10.  All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.

Authors:  Abdelrahman M Elsayed; Tamer M Abdelghany; El-Sayed Akool; Abdel-Aziz H Abdel-Aziz; Mohamed S Abdel-Bakky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.